関連する実験動画
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
ヌクレオソーム改変による表遺伝子細胞記憶の理論分析
Ian B Dodd1, Mille A Micheelsen, Kim Sneppen
1Center for Models of Life, Niels Bohr Institute, Blegdamsvej 17, DK-2100, Copenhagen Ø, Denmark.
Cell
|May 22, 2007
まとめ
エピジェネティック遺伝子の発現は,核細胞の改変により,二元化可能である. このビスタビリティは,単純に拡散するだけでなく,協力的な改変と非ローカルな効果を必要としていることをモデルが示しています.
科学分野:
- エピジェネティクスと分子生物学
- 計算生物学とシステム生物学
背景:
- 染色体領域は,DNA配列の変異なしに,遺伝子発現の安定した,遺伝可能な代替状態を示す.
- エピジェネティック・コントロールはヒストンの共性変異と関連しており,状態の安定のために提案されたポジティブなフィードバックメカニズムがある.
研究 の 目的:
- ダイナミックヌクレオソーム改変の簡素化されたストキャスティックモデルを開発する.
- 酵母をモデルとして用いて,表遺伝的調節におけるビスタブル遺伝子発現の基礎となるメカニズムを調査する.
主な方法:
- ヌクレオソーム改変ダイナミクスのための簡素化されたストカスティックモデルを開発した.
- *Schizosaccharomyces pombe*の静かな交配型領域に関連するパラメータを使用してモデルをシミュレートしました.
主要な成果:
- モデルは,改変の得損とDNA複製によるノイズに対する強いビスタビリティを実証しました.
- 頑丈なビスタビリティは,複数の核細胞を含む協力的な改変を必要とした.
- 直接の隣人を超えた変異の非局所的刺激を観察し,単純な拡散モデルに挑戦しました.
結論:
- 簡素化されたストキャスティックモデルは,強固な表遺伝子ビスタビリティを再現できます.
- 協同的および非局所的な核細胞改変メカニズムは,安定した表遺伝子状態にとって極めて重要です.
- 発見は,遺伝性遺伝子発現パターンの分子基礎についての洞察を提供します.
関連する概念動画
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K